Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

Diabetes Care · 2011 · PMC3064036 · PMID 21386088

Europe PMC DOI

hedged sentences

0.0690

closest p · 1.4× alpha

0.0690

boldest claim

The sentences

approached significanceP = 0.069so close (0.05 < p ≤ 0.1)

The difference between treatments in the MetS patients approached significance (TD 13.3% [−1 to 26]; P = 0.069) ( Fig. 1 ).

also in 8,237 other papers

showed a trendno p-value reported

The current study showed a trend for cardiovascular events to occur more frequently in the placebo group than in the TRT group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.